Noida, UP -- (SBWire) -- 09/26/2014 --RNCOS latest research report titled “Global Vaccine Market Outlook 2020”, estimates that the global vaccine market will grow at a healthy CAGR of around 12% during 2013-2020. It has been observed that majority of vaccines in Phase III clinical trials are for influenza treatment. Sanofi leads the global market for influenza vaccine. It generated revenue of over US$ 1 Billion in 2013 from sales of influenza preventing vaccines, Fluzone and Vaxigrip. The major companies working on influenza include Sanofi, Novartis, and AstraZeneca among a few others.
In the report, vaccine market has been classified based on 16 therapeutic categories and market for each has been forecasted till 2020. The report also covers advanced stage pipeline analysis of key players of this market which list down the vaccines already in Phase III trials. In addition to this, analysts have studied the business dynamics of key players in the industry. A brief business overview with their product portfolio has been provided in the report. Moreover, our team has also analyzed each company’s strengths and weaknesses along with its vaccine portfolio and pipeline that will help the reader to better position his/her company vis-à-vis competition.
The report provides a thorough research and rational analysis of the current status and expected position of the global vaccines market. It facilitates the future forecasts on the total vaccines market, therapeutic categories and regional markets. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify key opportunities and design suitable business strategies.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM697.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
Curing Influenza: Intense R&D for Vaccine Development
“Vaccine industry pipeline flooded with Influenza vaccines”, says RNCOS.